Agilent launches clinical lab systems for DNA, RNA analysis
Agilent Technologies has introduced two new TapeStationDx systems for quality control of DNA and RNA samples in clinical laboratories. The 4150 and 4200 systems carry CE-IVD labels, expanding Agilent's automated electrophoresis technology into regulated clinical environments. The systems can process 1 to 96 samples using tube strips or 96-well plates, with analysis taking approximately 1 to 2 minutes per sample.
The accompanying TapeStationDx software provides data acquisition, analysis, reporting, and export capabilities, with audit trails and electronic signatures to meet regulations such as 21 CFR Part 11 and EU Annex 11. Agilent will showcase the TapeStationDx portfolio at various scientific conferences in 2026. The company reported $6.95 billion in revenue for fiscal year 2025 and has around 18,000 employees worldwide.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
